WEB REGISTRATION CLOSES:
- 00Days
- 00Hrs
- 00Mins
- 00Secs
May 14-17, 2024 | In-Person + Digital
Boston, MA, USAHynes Convention Center Jiancun Larry Zhang, Ph.D.President and CEO at Guangzhou Henovcom BiosciencesSpeaker
Profile
Dr. Zhang obtained his BS degree in chemistry from Fudan University and his Ph. D degree in organic chemistry in 1990 from the University of Pittsburgh. After postdoctoral training at Duke University, he joined Gilead in 1992 working on various antisense ODN and antiviral projects. He is the co-founder of Henovcom Biosciences. Over the years, he has co-invented several NMEs that are marketed or in clinical development. He co-authored over 80 publications and is the co-inventors of over 100 patents and patent applications in organic and medicinal chemistry.
Agenda Sessions
Enhancing mRNA Translation Efficiency through Trinucleotide Cap Modifications
, 8:30amView Session